Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Clinical trial NCT05200936 · COMPLETED
Trial details
- NCT number
- NCT05200936
- Sponsor
- Definium Therapeutics US, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2023-11-06
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.